Effect of Chronic Supplementation of L-arginine in the Muscular Performance

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-10-31

Study Completion Date

2008-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of this study is to evaluate the effect of oral administration of L-arginine in the muscular fatigue of the quadriceps, expressed in terms of the Fatigue Resistance Factor (FRF). The secondary purpose of this study is to evaluate the effect of oral administration of L-arginine in the muscular force the quadriceps.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Orally Administered L- Arginine on Quadriceps Strenght in Healthy Smokers

NCT04643600

Spirometry Qadriceps Muscle

UNKNOWN PHASE4

The Effects of L-arginine Supplementation on Anaerobic Exercise Performance

NCT06475391

Skeletal Muscle Human Performance

RECRUITING NA

L-arginine Supplementation and Resistance Exercise

NCT03827005

Healthy Adult

COMPLETED NA

EFFECTS OF L-ARGININE SUPPLEMENTATION ON THE RECOVERY OF CARDIORESPIRATORY PARAMETERS AFTER SUBMAXIMAL EXERCISE TEST

NCT06405477

Nutrition, Healthy

RECRUITING NA

Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2)

NCT04637906

Covid19

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Muscular Fatigue

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

L-arginine aspartate (Targifor)

Group Type EXPERIMENTAL

L-arginine aspartate (Targifor)

Intervention Type DRUG

3g of L-arginine taken orally in a single daily dose for 8 weeks

2

Placebo

Group Type PLACEBO_COMPARATOR

Placebo L-arginine aspartate (Targifor)

Intervention Type DRUG

Placebo of L-arginine taken orally in a single daily dose for 8 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

L-arginine aspartate (Targifor)

3g of L-arginine taken orally in a single daily dose for 8 weeks

Intervention Type DRUG

Placebo L-arginine aspartate (Targifor)

Placebo of L-arginine taken orally in a single daily dose for 8 weeks

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Healthy young adults for both sex; Age between 20 and 55 years; Slight or moderate physical activity, 30 minutes per day, at least 3 times a week;

Exclusion Criteria

Cardiac or pulmonary disease; Previous history of knee surgery or skeletal muscular dysfunctions in hip, knee or ankle joints; Athletic person (intensive anaerobic activity); None practiced of physical activity regularly; Medications usage

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Minimum Eligible Age

20 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes